{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T21:00:33Z","timestamp":1785013233433,"version":"3.55.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The National Key Research and Development Program of China","award":["2020YFA0908200 and 2020YFA0710800"],"award-info":[{"award-number":["2020YFA0908200 and 2020YFA0710800"]}]},{"name":"the Key Program of the National Natural Science Foundation of China","award":["the Key Program of the National Natural Science Foundation of China"],"award-info":[{"award-number":["the Key Program of the National Natural Science Foundation of China"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["T2225003, 82001719, 52073060, and 61927805"],"award-info":[{"award-number":["T2225003, 82001719, 52073060, and 61927805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Jiangsu","award":["BE2018707"],"award-info":[{"award-number":["BE2018707"]}]},{"name":"the Nanjing Medical Science and Technique Development Foundation","award":["ZKX21019"],"award-info":[{"award-number":["ZKX21019"]}]},{"name":"the Clinical Trials from Nanjing Drum Tower Hospital","award":["2022-LCYI-ZD-01"],"award-info":[{"award-number":["2022-LCYI-ZD-01"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Osteoarthritis (OA) is a prevalent chronic joint disorder among middle-aged and older adults, characterized by progressive cartilage degeneration, subchondral bone remodeling, and osteophyte formation, leading to joint pain, stiffness, dysfunction, and reduced quality of life. With the global aging population, OA imposes a growing socioeconomic burden, yet no disease-modifying therapy is currently available\u2014particularly for moderate-to-severe stages. Emerging evidence implicates synovial inflammation as a central contributor to OA symptoms and progression, raising interest in methotrexate (MTX), a well-established, low-dose anti-inflammatory agent used safely in rheumatoid arthritis. Preliminary studies suggest MTX may alleviate OA-related pain, but findings from randomized controlled trials (RCTs) have been inconsistent and limited in number. Given recent new RCTs and the heterogeneity of existing outcomes, an updated systematic review and meta-analysis is urgently needed to clarify the efficacy and safety of MTX in OA and inform future clinical trial design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>PubMed, ClinicalTrials, Web of Science, Cochrane Library and other databases were searched to find randomized controlled trials (RCT) of MTX treatment of OA. Methodological quality was assessed using the Cochrane \"risk of bias\" assessment tool, and the meta-analysis was conducted using Review Manager (RevMan) version 5.3 (The Cochrane Collaboration, London, UK).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fifteen RCTs involving 1591 participants were included in this review. The meta-analysis results showed that the ineffective rate in the experimental group was lower [RR: 0.40 (0.24, 0.67),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.004]; the VAS in the experimental group was lower [WMD: \u22120.66 (\u22121.08, \u22120.24),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.002]; the WOMAC score-stiffness in the experimental group was lower [WMD: \u22120.72 (\u22121.04, \u22120.41),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001]; the WOMAC score-function in the experimental group was lower [WMD: \u22127.72 (\u221213.56, \u22121.87),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.01]. The adverse events in the experimental group were not statistically significant compared with the control group [RR: 1.04 (0.77, 1.42),\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.78].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>MTX demonstrates potential in effectively alleviating pain, improving joint function, and slowing disease progression in patients with OA. Its safety profile is comparable to that of control treatments, making it a viable and reliable therapeutic option worthy of broader clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044994","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:02:04Z","timestamp":1760331724000},"page":"e44994","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The effectiveness and safety of methotrexate in the intervention of osteoarthritis: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1097","volume":"104","author":[{"given":"Lifei","family":"Wan","sequence":"first","affiliation":[{"name":"People\u2019s Hospital of Ningxiang City, Ningxiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3708-9007","authenticated-orcid":false,"given":"Qianyue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailin","family":"Yang","sequence":"additional","affiliation":[{"name":"Hunan University of Chinese Medicine, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuting","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260113","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","article-title":"Osteoarthritis.","volume":"386","author":"Glyn-Jones","year":"2015","journal-title":"Lancet"},{"key":"R2-20260113","doi-asserted-by":"crossref","first-page":"99","DOI":"10.20344\/amp.5477","article-title":"Osteoarthritis.","volume":"28","author":"Pereira","year":"2015","journal-title":"Acta Med Port"},{"key":"R3-20260113","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-155-11-201112060-00004","article-title":"Increasing prevalence of kmnee pain and symptomatic knee ostearthritis: survey and cohort data.","volume":"155","author":"Nguyen","year":"2011","journal-title":"Ann Intern Med"},{"key":"R4-20260113","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cger.2010.03.001","article-title":"Epidemiology of osteoarthritis.","volume":"26","author":"Zhang","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"R5-20260113","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/annrheumdis-2013-204763","article-title":"The global burden of hip and knee osteoarthitis: estimates from the global burden of disease 2010 study.","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R6-20260113","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.joca.2017.11.014","article-title":"Osteoarthritis year in review 2017: clinical.","volume":"26","author":"Nelson","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"R7-20260113","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","article-title":"Osteoarthritis: pathology, diagnosis, and treatment options.","volume":"104","author":"Abramoff","year":"2020","journal-title":"Med Clin North Am"},{"key":"R8-20260113","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.rehab.2016.02.005","article-title":"Educating patients about the benefits of physical activity and exercise for their hip and knee osteoarthritis. Systematic literature review.","volume":"59","author":"Gay","year":"2016","journal-title":"Ann Phys Rehabil Med"},{"key":"R9-20260113","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0140-6736(18)31064-X","article-title":"Osteoarthritis.","volume":"391","author":"Barnett","year":"2018","journal-title":"Lancet"},{"key":"R10-20260113","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jor.23471","article-title":"Chemokines and inflammation in osteoarthritis: insights from patients and animal models.","volume":"35","author":"Scanzello","year":"2017","journal-title":"J Orthop Res"},{"key":"R11-20260113","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis.","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"R12-20260113","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2217\/pgs-2019-0121","article-title":"Methotrexate pharmacogenetics in the treatment of rheumatoid arthritis.","volume":"20","author":"Jekic","year":"2019","journal-title":"Pharmacogenomics"},{"key":"R13-20260113","first-page":"S65","article-title":"Long-term safety of methotrexate in the treatment of rheumatoid arthritis.","volume":"28","author":"Yazici","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R14-20260113","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/rheumatology\/kes386","article-title":"Methotrexate for pain relief in knee osteoarthritis: an open-label study.","volume":"52","author":"Wenham","year":"2013","journal-title":"Rheumatology"},{"key":"R15-20260113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13063-015-0602-8","article-title":"Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.","volume":"16","author":"Kingsbury","year":"2015","journal-title":"Trials"},{"key":"R16-20260113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10787-024-01604-x","article-title":"Methotrexate for osteoarthritis: a systematic review meta-analysis of randomized controlled trials.","volume":"33","author":"Queiroz","year":"2025","journal-title":"Inflammopharmacology"},{"key":"R19-20260113","first-page":"595","article-title":"Analysis of the efficacy of methotrexate combined with diclofenac in the treatment of osteoarthritis in 60 cases.","author":"Chen","year":"2008","journal-title":"New Med"},{"key":"R20-20260113","first-page":"3886","article-title":"Clinical study of methotrexate combined with diclofenac in the treatment of osteoarthritis.","volume":"33","author":"Chen","year":"2012","journal-title":"Jilin Med"},{"key":"R21-20260113","first-page":"137","article-title":"Clinical effect of methotrexate for injection combined with sodium hyaluronate injection in the treatment of osteoarthritis.","volume":"23","author":"Song","year":"2016","journal-title":"China Contemporary Med"},{"key":"R22-20260113","first-page":"42","article-title":"The clinical effect and safety of intra-articular injection of methotrexate in the treatment of knee osteoarthritis.","volume":"5","author":"Liu","year":"2020","journal-title":"Clin Med Res Pract"},{"key":"R23-20260113","first-page":"420","article-title":"Clinical study of methotrexate combined with loxoprofen sodium in the treatment of knee osteoarthritis.","volume":"15","author":"Li","year":"2015","journal-title":"Chin Med Clin"},{"key":"R24-20260113","first-page":"2834","article-title":"Clinical efficacy of methotrexate combined with non-steroidal anti-inflammatory drugs for symptomatic knee osteoarthritis.","volume":"24","author":"Kong","year":"2013","journal-title":"Hainan Med J"},{"key":"R25-20260113","first-page":"9","article-title":"Ultrasound-guided intraarticular injection of methotrexate for the treatment of knee osteoarthritis.","volume":"45","author":"Lomei","year":"2018","journal-title":"China Pract Med J"},{"key":"R26-20260113","doi-asserted-by":"crossref","first-page":"e89990","DOI":"10.5812\/aapm.89990","article-title":"Efficacy of methotrexate on pain severity reduction and improvement of quality of life in patients with moderate to severe knee osteoarthritis.","volume":"9","author":"Enteshari-Moghaddam","year":"2019","journal-title":"Anesth Pain Med"},{"key":"R27-20260113","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1590\/S0482-50042007000500008","article-title":"Baixa dose de methotrexate comparado a placebo emosteoartrite de joelho.","volume":"47","author":"de Holanda","year":"2007","journal-title":"Revista Brasileira de Reumatologia"},{"key":"R28-20260113","first-page":"169","article-title":"Efficacy and safety analysis of methotrexate combined with diclofenac in the treatment of osteoarthritis.","author":"Zhang","year":"2012","journal-title":"Med Front"},{"key":"R29-20260113","first-page":"45","article-title":"The effect of compound betamethasone combined with methotrexate in the treatment of knee osteoarthritis.","volume":"28","author":"Lin","year":"2020","journal-title":"Clin Res"},{"key":"R30-20260113","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.semarthrit.2021.04.016","article-title":"Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial.","volume":"51","author":"Ferrero","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R31-20260113","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(23)01572-6","article-title":"Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial.","volume":"402","author":"Wang","year":"2023","journal-title":"Lancet"},{"key":"R32-20260113","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jamainternmed.2025.1359","article-title":"Low-dose methotrexate for the treatment of inflammatory knee osteoarthritis: a randomized clinical trial.","volume":"185","author":"Zhu","year":"2025","journal-title":"JAMA Intern Med"},{"key":"R33-20260113","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.7326\/M24-0303","article-title":"Pain reduction with oral methotrexate in knee osteoarthritis: a randomized, placebo-controlled clinical trial.","volume":"177","author":"Kingsbury","year":"2024","journal-title":"Ann Intern Med"},{"key":"R34-20260113","first-page":"36","article-title":"Clinical observation of diclofenac combined with methotrexate in the treatment of osteoarthritis.","volume":"31","author":"Chen","year":"2012","journal-title":"Chin Manipulation Rehabil Med"},{"key":"R35-20260113","first-page":"56","article-title":"Preliminary observation of the effect of intra-articular injection of methotrexate and dexamethasone on knee osteoarthritis.","volume":"16","author":"Cao","year":"2003","journal-title":"Shenyang Army Med"},{"key":"R36-20260113","first-page":"B5464","article-title":"Assessing synovitis with conventional static and dynamic contrast-enhanced magnetic resonance imaging in knee osteoarthritis.","volume":"65","author":"Riis","year":"2018","journal-title":"Dan Med J"},{"key":"R37-20260113","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/jcp.26011","article-title":"Histomorphology and innate immunity during the progression of osteoarthritis:does synovitis affect cartilage degradation?","volume":"233","author":"Wang","year":"2018","journal-title":"J Cell Physiol"},{"key":"R38-20260113","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/rheumatology\/keu279","article-title":"Methotrexate-mediated inhibition of nuclear factorkB activation by distinct pathways in T cells and fibroblast-like synoviocytes.","volume":"54","author":"Spurlock","year":"2015","journal-title":"Rheumatology"},{"key":"R39-20260113","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/rheumatology\/39.6.637","article-title":"Enhanced production of tissue inhibitor of metalloproteinases by peripheral blood mononuclear cells of rheumatoid arthritis patients responding to methotrexate treatment.","volume":"39","author":"Seitz","year":"2000","journal-title":"Rheumatology"},{"key":"R40-20260113","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2014-206927","article-title":"Synovial tissue volume:a treatment target in knee osteoarthritis (OA).","volume":"75","author":"O\u2019neill","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R41-20260113","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/os.13809","article-title":"Research progress on the pathogenesis of knee osteoarthritis.","volume":"15","author":"Du","year":"2023","journal-title":"Orthop Surg"},{"key":"R42-20260113","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3892\/etm.2023.12180","article-title":"Knee osteoarthritis: current status and research progress in treatment (Review).","volume":"26","author":"Geng","year":"2023","journal-title":"Exp Ther Med"},{"key":"R43-20260113","doi-asserted-by":"crossref","first-page":"113074","DOI":"10.1016\/j.biopha.2022.113074","article-title":"Application and pharmacological mechanism of methotrexate in rheumatoid arthritis.","volume":"150","author":"Zhao","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R44-20260113","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis.","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat Rev Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:03:20Z","timestamp":1768334600000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":42,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044994","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"2025-05-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}